Skip to main content

Prescription medicine

Calcium chloride, magnesium chloride and 3 other ingredients Brand names: Tpn; first approved as Tpn Electrolytes

Calcium chloride, magnesium chloride and 3 other ingredients (Tpn) is a prescription medicine with an FDA approval on record since 1984. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the calcium chloride, magnesium chloride and 3 other ingredients FDA label on DailyMed (effective May 25, 2026, Hospira, Inc.); the NDA 18895 record on Drugs@FDA; every calcium chloride, magnesium chloride and 3 other ingredients label on DailyMed.

Highlights of the record

FDA label of May 25, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

TPN Electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients.

Forms and strengths

  • 321 mg/20ml / 331 mg/20ml / 1491 mg/20ml / 508 mg/20ml / 2420 mg/20ml

Injection (solution) (concentrate).

On the market

Earliest approval on file
July 20, 1984 Tpn Electrolytes In Plastic Container, Hospira; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
34 through July 30, 2026

What is calcium chloride, magnesium chloride and 3 other ingredients used for?

From the label: indications and usage

TPN Electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients.

FDA pharmacologic class: Blood Coagulation Factor, Calculi Dissolution Agent, Osmotic Laxative, Phosphate Binder and Potassium Salt.

Source: FDA drug label (TPN Electrolytes), Hospira, Inc., effective May 25, 2026 (SPL set c00817bc-7b62-4abe-0280-e7930eda3f94), via openFDA; the full label on DailyMed

Is there a generic for calcium chloride, magnesium chloride and 3 other ingredients (Tpn)?

No generic calcium chloride, magnesium chloride and 3 other ingredients is approved (Drugs@FDA, October 8, 2026).

  • 1984 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do FAERS reports show for calcium chloride, magnesium chloride and 3 other ingredients?

The FDA Adverse Event Reporting System holds 34 reports that list calcium chloride, magnesium chloride and 3 other ingredients among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 6 are coded as a death and 15 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Nausea4
  • Vomiting4
  • Urticaria3
  • Cough2
  • Covid-192
  • Death (an outcome recorded in the report)2
  • Fungaemia2
  • Hepatic Failure2

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other blood coagulation factors
the pharmacologic class, with prices and generics
Check an interaction
what two or more labels say about each other